Amlodipine

Major

Amlodipine Relacorilant Lifyorli Increased CYP3A4 substrate exposure and an increased risk of CYP3A4-substrate-related adverse reactions Details Amlodipine Repotrectinib Augtyro Reduced amLODIPine exposure Details Amlodipine Ribociclib Kisqali Increased amLODIPine exposure and an increased risk of hypotension and edema Details Amlodipine Rifabutin Mycobutin Reduced amLODIPine exposure Details Amlodipine Rifampin Rifadin Reduced amLODIPine exposure Details Amlodipine Ritlecitinib Litfulo Increased amLODIPine exposure and an increased risk of hypotension and edema Details Amlodipine Ritonavir Norvir Increased amLODIPine exposure, an increased risk of hypotension and edema and reduced amLODIPine exposure Details Amlodipine Roflumilast Daliresp Increased roflumilast exposure and an increased risk of roflumilast-related adverse events Details Amlodipine Rufinamide Banzel Reduced amLODIPine exposure Details Amlodipine Safinamide Xadago Reduced amLODIPine exposure Details Amlodipine Saquinavir Increased amLODIPine exposure and an increased risk of hypotension and edema Details Amlodipine Sarilumab Reduced amLODIPine exposure Details Amlodipine Schizandra Increased amLODIPine exposure and an increased risk of hypotension and edema Details Amlodipine Sildenafil Liqrev Potentiation of hypotensive effects Details Amlodipine Sotagliflozin Inpefa Reduced amLODIPine exposure Details Amlodipine Sotorasib Lumakras Reduced amLODIPine exposure Details Amlodipine Stiripentol Diacomit Increased amLODIPine exposure and an increased risk of hypotension and edema Details Amlodipine St John's Wort Reduced amLODIPine exposure Details Amlodipine Sulfinpyrazone Reduced amLODIPine exposure Details Amlodipine Suzetrigine Journavx Reduced amLODIPine exposure Details Amlodipine Tacrolimus Astagraf Increased tacrolimus exposure Details Amlodipine Tazemetostat Tazverik Reduced CYP3A substrate exposure and reduced efficacy of CYP3A substrate Details Amlodipine Tecovirimat Reduced amLODIPine exposure Details Amlodipine Tegafur Decreased exposure of 5-fluorouracil Details Amlodipine Telaprevir Increased amLODIPine exposure, an increased risk of hypotension and edema and reduced amLODIPine exposure Details Amlodipine Telithromycin Increased amLODIPine exposure and an increased risk of hypotension and edema Details Amlodipine Telotristat Ethyl Xermelo Reduced amLODIPine exposure Details Amlodipine Terbinafine Lamisil Reduced amLODIPine exposure Details Amlodipine Thioridazine Reduced amLODIPine exposure Details Amlodipine Ticagrelor Brilinta Reduced amLODIPine exposure Details Amlodipine Ticlopidine Ticlid® Reduced amLODIPine exposure Details Amlodipine Topiramate Eprontia Reduced amLODIPine exposure Details Amlodipine Tovorafenib Ojemda Reduced amLODIPine exposure Details Amlodipine Tramadol ConZip Increased traMADol exposure and an increased risk of seizures, serotonin syndrome and opioid toxicity Details Amlodipine Treosulfan Grafapex Increased amLODIPine exposure and an increased risk of hypotension and edema Details Amlodipine Troglitazone Reduced amLODIPine exposure Details Amlodipine Troleandomycin Increased amLODIPine exposure and an increased risk of hypotension and edema Details Amlodipine Tucatinib Tukysa Increased amLODIPine exposure and an increased risk of hypotension and edema Details Amlodipine Upadacitinib Rinvoq Reduced amLODIPine exposure Details Amlodipine Vemurafenib Zelboraf Reduced amLODIPine exposure Details